In Brief: J&J
This article was originally published in The Rose Sheet
Executive Summary
J&J: Pays off debt incurred from the acquisition of Neutrogena and Clinical Diagnostics, Johnson & Johnson Chairman Ralph Larsen announces April 27 at the company's annual meeting. In fact, Larsen says, J&J's net debt is "$100 mil. lower than it was a year ago." The company has indicated that it is again considering acquisitions...